β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly <i>via</i> CB2 and Non-CB2 Receptor Mechanisms.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiang-Hu,He

第一单位： Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, United States.

作者： Xiang-Hu,He ^[1] ; Ewa,Galaj ^[2] ; Guo-Hua,Bi ^[1] ; Yi,He ^[1] ; Briana,Hempel ^[1] ; Yan-Lin,Wang ^[1] ; Eliot L,Gardner ^[2] ; Zheng-Xiong,Xi ^[1]

作者单位： Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD, United States. ^[1] Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Hubei, China. ^[2]

关键词 CB2 receptor dopamine methamphetamine reinstatement self-administration β-caryophyllene

DOI 10.3389/fphar.2021.722476

PMID 34566647

发布时间 2021-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2021年12卷

722476页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly <i>via</i> CB2 and Non-CB2 Receptor Mechanisms.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly <i>via</i> CB2 and Non-CB2 Receptor Mechanisms.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除